Perkin Elmer Updates Q2 Outlook Perkin Elmer has today revised their outlook for Q2, announcing that they expect growth of approximately 12% for the second quarter ended July 5, 2020. The strong revenue growth was driven by better-than-expected demand for solutions aimed at COVID-19 testing needs across the globe. Demand for the Company’s RT-PCR and […]
Spectris PLC, the holding company for businesses such as Malvern Instruments, PANalytical and Particle Measuring Systems has today announced their Trading Update for the period from July 1 to October 31 2016. Reported revenues have increased by 18% for the 4 month period, which are attributed to group acquisitions and positive impacts of currency exchange […]
Spectris plc (SXS: LSE) is a UK holding company that listed on the London Stock Exchange in 1988. Today they own several companies in the laboratory technologies space including; Malvern Instruments, Particle Measuring Systems, PANalytical, Servomex and NDC Technologies. Spectris reported revenues for 2015 that are flat on a like for like basis, compared with […]
PerkinElmer has today announced result for FY 2015. The company reports full year revenues of $2.26 billion which is a year on year organic growth of 4% or 7% on a constant currency basis. Net income for the year grew by 35% to $212 million. Robert Friel, Chairman and CEO said, “I am very pleased […]
“After a slow start in the first half-year 2015, our business picked up well in the third and fourth quarters, allowing us to fully achieve our targets for 2015. Thanks to the successful integration of Vysionics, acquired in 2014, our ongoing internationalization process and the consistent execution of our efficiency programs, we managed to increase […]
Spectris is one of the UK’s leading suppliers of productivity enhancing instrumentation and controls. They own several well known brands working in the laboratory instrumentation space providing a global footprint. Companies such as Malvern Instruments (Malvern, UK), Particle Measuring Systems (Boulder, CO), PANalytical (Almelo, Netherlands), NDC Technologies (Irwindale, CA) and Servomex (Crowborough, UK) all fall […]
Bruker Corporation (NASDAQ: BRKR) today reported financial results for its first quarter ended March 31, 2015. Bruker’s revenues for the first quarter of 2015 were $353.5 million, a decline of 16.6 percent compared to the first quarter of 2014. Excluding a 2.6 percent net negative effect from acquisitions & divestitures, and an 11.0 percent negative effect […]
“Our strong fourth quarter and fiscal year 2014 results mark the conclusion of another successful year for the Company,” said Vincent A. Forlenza, Chairman, CEO and President. “Organic revenue growth continued to accelerate and we delivered a higher quality of earnings while maintaining our ongoing investments to support our innovation strategy. We have built […]
FEI Company (Nasdaq:FEIC) reported results for third quarter of 2014. Revenue of $227.8 million was up 4.2% compared to $218.5 million in the third quarter of 2013 and down 3.9% compared to $237.0 million in the second quarter of 2014. Net bookings in the third quarter were $250.1 million with a book-to-bill ratio of […]
Pacific Biosciences of California, Inc. (Nasdaq:PACB) today reported a 178% increase in revenue to $20.6 million for the third quarter ended September 30, 2014, compared to $7.4 million for the third quarter of 2013. Third quarter 2014 revenue included the achievement of the $10.0 million milestone related to Roche along with the $1.7 million quarterly amortization from the upfront Roche payment in addition to […]
“We’re pleased to extend our long track record of consistently delivering strong adjusted EPS growth,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “We leveraged our solid top-line results and our culture of operational discipline to achieve excellent performance on the bottom line. I’m also pleased to report that […]
Waters Corporation (NYSE:WAT) reported today third quarter 2014 sales of $493 million, an increase of 8% versus sales of $457 million in the third quarter of 2013. In the quarter, the effect of foreign currency translation was neutral to sales growth. On a GAAP basis, earnings per diluted share (EPS) for the third quarter were $1.34 compared to $1.14 for the third […]